West Africa prepares for Ebola vaccination programAmidst the COVID-19 pandemic, West Africa is facing a new outbreak of Ebola. A global emergency stockpile of Share XWest Africa prepares for Ebola vaccination programhttps://pharmaphorum.com/views-and-analysis/west-africa-prepares-for-ebola-vaccination-program/
Guinea declares Ebola epidemic following first deaths since 2016Guinea has officially declared it is dealing with an Ebola epidemic, after at least three people died from Share XGuinea declares Ebola epidemic following first deaths since 2016https://pharmaphorum.com/news/guinea-declares-ebola-epidemic-following-first-deaths-since-2016/
Regeneron’s antibody cocktail approved by FDA for EbolaAn antibody cocktail from Regeneron has been approved by the FDA as the first treatment for Ebola, offering Share XRegeneron’s antibody cocktail approved by FDA for Ebolahttps://pharmaphorum.com/news/regenerons-antibody-cocktail-approved-by-fda-for-ebola/
Regeneron’s Ebola drug heading for October verdict from FDAThe FDA has kicked off a six-month priority review of REGN-EB3, Regeneron’s three-drug therapy for Ebola virus infection, Share XRegeneron’s Ebola drug heading for October verdict from FDAhttps://pharmaphorum.com/news/regenerons-ebola-drug-heading-for-october-verdict-from-fda/
Merck claims first-ever FDA approval for an Ebola vaccineMerck & Co’s Ebola vaccine Ervebo has been cleared for marketing in the US, just weeks after getting Share XMerck claims first-ever FDA approval for an Ebola vaccinehttps://pharmaphorum.com/news/merck-claims-first-ever-fda-approval-for-an-ebola-vaccine/
CHMP backs world’s first Ebola vaccine from MSD, NewLinkMerck & Co/MSD’s Ebola vaccine has been recommended for conditional approval by the EMA’s main advisory committee, teeing Share XCHMP backs world’s first Ebola vaccine from MSD, NewLinkhttps://pharmaphorum.com/news/chmp-backs-worlds-first-ebola-vaccine-from-msd-newlink/
Merck & Co in pole position for Ebola vaccine approval as FDA begins reviewThe FDA is to review Merck & Co’s Ebola vaccine, giving the US pharma a chance to grab Share XMerck & Co in pole position for Ebola vaccine approval as FDA begins reviewhttps://pharmaphorum.com/news/fda-to-review-merck-cos-ebola-vaccine/
First effective Ebola treatment a step closer after breakthrough trialClinical trials of four experimental treatments for Ebola in the Congo have been halted early after two of Share XFirst effective Ebola treatment a step closer after breakthrough trialhttps://pharmaphorum.com/news/ebola-virus-clinical-trial-breakthrough/
GSK exits Ebola vaccine R&D as J&J rival starts Uganda trialGlaxoSmithKline has licensed vaccines for Ebola to the US Sabin Vaccine Institute, just as a major trial of Share XGSK exits Ebola vaccine R&D as J&J rival starts Uganda trialhttps://pharmaphorum.com/news/gsk-exits-ebola-vaccine-rd-as-jj-rival-starts-uganda-trial/
